Normal Saline Infusion for Stroke After Intravenous Thrombolysis
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 241 participants.
Also called NCT05993078
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 241 participants
- Registry
-
NCT05993078
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05993078. Randomized; double masking; primary purpose treatment. Start 2023-09-01 (actual); primary completion 2024-12-20 (actual). Results posted on 2025-03-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Normal Saline Infusion for Stroke After Intravenous Thrombolysis
- Acronym
- NS-STAR
- Condition
- Brain Infarct
- Intervention (Drug)
- 0.9% NaCl 2000ml
- Intervention (Drug)
- 0.9% NaCl 200-400ml
- Lead sponsor
- Tianjin Medical University General Hospital
- Collaborator
- Affliated Hospital of Jiujiang University
- Collaborator
- Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine
Record details
- Record id
cardio:ct-nct05993078- Content hash
50f659c79c01e68b67ca35f475b1186bac0b9646f9487d478b6418abbfc42b43